Acute kidney injury in patients with cancer receiving anti-PD-1/PD-L1 antibodies: incidence, risk factors, and prognosis-Reference-Cited by-同舟云学术

Acute kidney injury in patients with cancer receiving anti-PD-1/PD-L1 antibodies: incidence, risk factors, and prognosis

Published:2023-07-25 Issue:1 Volume:45 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Lou Qianqian¹²,Gong Jianguang²,Ye Binxian²,Yu Rizhen²,Bu Shuangshan¹,Li Yiwen²,Zhu Bin²,Shao Lina²^ORCID

Affiliation:

1. Department of Nephrology, Dongyang Hospital (Affiliated Wenzhou University), Zhejiang, China

2. Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China

Funder

National Natural Science Foundation of China under Grant

Medical Science and Technology Project of Zhejiang Province

Dongyang Science and Technology Plan Project

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2023.2238823

Reference43 articles.

1. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

2. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

5. Cutaneous adverse events caused by immune checkpoint inhibitors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody vs. immune checkpoint inhibitors: a retrospective real-world study;BMC Cancer;2024-06-24

2. Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience;Journal of Oncology Pharmacy Practice;2024-05-05

3. Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor;IRAN J KIDNEY DIS;2024

4. All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality;Clinical Kidney Journal;2023-11-28

5. Multiple drugs;Reactions Weekly;2023-09-09